REC-4539 An investigational reversible, brain-penetrant LSD1 inhibitor in Phase 1 development for solid tumors and hematologic cancers.
Visit productCosigns Received
Be the first Cosign
Put your name behind REC-4539.
Add it to your Products I use list and share why you use it.